Please Click Here to upgrade your Flash player at macromedia.com
Genesis Genomics

Welcome to Genesis Genomics

Genesis Genomics Inc. is the world leader and a pioneer in the research, discovery, development and commercial application of mitochondrial DNA (“mtDNA”) based biomarkers for a wide spectrum of human diseases.

image

Since its founding in 2001, Genesis has developed unmatched expertise in the field of
mitochondria and mtDNA and has leveraged this expertise to create:

  • Immediate opportunities to enter the fast growing and highly profitable molecular diagnostic market with a significant pipeline of efficient, low cost, screening, diagnostic, and treatment monitoring capabilities
  • Dramatic new insights into drug discovery, treatment pathways, and mitochondria function through a proprietary, novel, IP autonomous, unreported library of thousands of newly discovered mtDNA associated molecules
  • Significant future opportunities for differentiated diagnostic, therapeutic, and personalized healthcare products covering cancer, neurological disorders, diabetes, and other diseases through the full integration of Genesis’ technology with leading drug and diagnostic development platforms

Based on its encompassing core technology, Genesis Genomics has:

  • Launched mtDNA tests for: 1) assessing the genetic risk associated with ultraviolet radiation (‘UVR’) induced DNA damage, and 2) measuring the amount of DNA damage resulting from UVR exposure
  • Developed tests which are ready to be commercialized for : 1) identifying false negatives in prostate biopsies through the detection of underlying molecular alterations in histologically normal tissue, and 2) assessing the protective and therapeutic efficacy of compounds targeting UVR induced DNA damage
  • Created a robust pipeline of highly sensitive, highly specific biomarkers and tests - up to 96% AUC/ROC -  for high burden disease conditions including lung, colorectal, breast, and prostate cancer and melanoma, all of which currently have limited early-stage, non-invasive alternatives; each representing a $10.0 billion plus market opportunity
image At Genesis Genomics, our focus is to develop new technologies that extend life, reduce treatment cost, and improve quality of life for cancer patients and other patients.

Genesis Genomics is proud of the fact that we have been named one of Canada's Top 10 Life Science Companies

image

 

 

 

To Market - Genesis Genomics' Products Unveiled
Beauty may only be skin deep, but the damage some people incur attempting ...
read more
Canada's Top 10 Winner
Chosen as one of Canada's Top 10 Life Sciences Companies for 2008 ...
read more
Genesis & the Barcode of Life
Genesis is proud to announce its participation in an NSERC funded ...
read more
Sencia, Corporate Web Solutions, Content Management Systems, Web Application Development